Short answer: No—there are no generic versions of Latuda (lurasidone) approved in the United States or most other major markets. The only way to get the drug is via its brand‑name product, although the active ingredient, lurasidone, is the generic name.
---
Why there are no generics
| Reason | Explanation |
|--------|-------------|
| Patent protection | Lurasidone is protected by patents that cover the drug’s formulation, manufacturing process, and indications. These patents expire in the next few years (2025–2027 in the U.S.), after which generic manufacturers may enter the market. |
| Brand‑name exclusivity | The manufacturer, Otsuka, has been granted exclusive rights to sell the drug in its brand form. No other company can legally market a “generic” version until the patents and exclusivity periods lapse. |
| Regulatory status | The FDA has approved only the brand name Latuda for schizophrenia and bipolar depression. A generic would have to go through its own FDA review, which hasn’t happened yet. |
---
What does “generic” mean in this context?
- Lurasidone is the chemical name of the active substance. Once patents expire, other companies can produce “lurasidone” (the same active ingredient) in any formulation that meets FDA standards.
- Generic lurasidone would be sold under that generic name rather than Latuda. It would contain the same amount and type of active ingredient, but the inactive ingredients, manufacturing process, and branding might differ.
---
Current availability
| Region | Brand name available | Generic available |
|--------|---------------------|-------------------|
| United States | Latuda (brand) | No (pending patents) |
| Canada | Latuda (brand) | No (pending patents) |
| Europe | Latuda (brand) | No (pending patents) |
| Other countries | Varies | Some markets have generic lurasidone sold under local names (e.g., “Lurasidone” in India), but these are not yet available in the U.S. |
---
Practical take‑aways for patients
- Prescription: You’ll need a prescription for Latuda from your healthcare provider. The pharmacist will dispense the brand‑name medication.
- Cost: Because there are no generics yet, the cost may be higher than for some other atypical antipsychotics. Check with your insurance; some plans offer a “generic‑only” option that covers brand‑name drugs at a lower co‑pay.
- Future: Keep an eye on the FDA’s generic approval docket. Once a generic lurasidone is approved, it could reduce costs substantially.
---
Bottom line
As of now, Latuda is still a brand‑name drug. The generic name for the active ingredient is lurasidone, but no generic formulation has been approved or marketed in the U.S. (or most other major markets). When the patents expire, generic manufacturers may bring lurasidone to market, which could make the medication more affordable.